HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keiju Hiromura Selected Research

Niceritrol

12/2010Successful treatment of lipoprotein glomerulopathy in a daughter and a mother using niceritrol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Keiju Hiromura Research Topics

Disease

16Proteinuria
01/2022 - 02/2007
9Rheumatoid Arthritis
01/2018 - 09/2003
7Lupus Nephritis
01/2022 - 06/2011
7Ureteral Obstruction
01/2019 - 01/2004
6Nephrotic Syndrome (Syndrome, Nephrotic)
01/2022 - 12/2007
6Glomerulonephritis
01/2021 - 08/2010
6Membranous Glomerulonephritis (Membranous Nephropathy)
10/2020 - 01/2003
6Fibrosis (Cirrhosis)
01/2019 - 01/2004
5Chronic Kidney Failure (Chronic Renal Failure)
09/2022 - 07/2013
5Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 06/2012
5Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/2017 - 05/2010
4Dermatomyositis (Dermatopolymyositis)
11/2022 - 10/2019
3Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
08/2022 - 01/2019
3Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
01/2022 - 12/2012
3Hypertrophy
01/2020 - 05/2002
3Inflammation (Inflammations)
01/2019 - 08/2012
3Neoplasms (Cancer)
11/2018 - 01/2005
3IGA Glomerulonephritis (IGA Nephropathy)
12/2012 - 01/2008
3AIDS-Associated Nephropathy (HIV-Associated Nephropathy)
08/2009 - 02/2007
2Polymyositis
11/2022 - 01/2021
2Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
01/2022 - 01/2022
2Infections
09/2021 - 06/2004
2Vasculitis (Vasculitides)
09/2021 - 09/2016
2Hemorrhage
01/2021 - 01/2019
2Melanoma (Melanoma, Malignant)
01/2021 - 12/2019
2Nephritis
07/2020 - 12/2012
2Acute Kidney Injury (Acute Renal Failure)
11/2018 - 01/2018
2Reperfusion Injury
01/2018 - 03/2012
2Pancytopenia
07/2014 - 06/2004
2Albuminuria
09/2013 - 10/2007
2Rheumatic Diseases (Rheumatism)
09/2012 - 01/2005
2Pneumonia (Pneumonitis)
01/2011 - 12/2005
2Wounds and Injuries (Trauma)
08/2009 - 10/2007
1Bilateral Hearing Loss
08/2022
1Otitis Media
08/2022
1Disease Progression
05/2022
1Central Nervous System Lupus Vasculitis
01/2022
1Lymphoma (Lymphomas)
01/2022
1Obesity
01/2022
1Pre-Eclampsia (Preeclampsia)
08/2021
1Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
01/2021
1Skin Manifestations
10/2019
1Rapidly progressive glomerulonephritis with pulmonary hemorrhage
01/2019
1Kidney Diseases (Kidney Disease)
01/2019
1Lung Neoplasms (Lung Cancer)
11/2018

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
11/2020 - 05/2002
6CreatinineIBA
09/2022 - 01/2008
6Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
08/2022 - 12/2012
6SteroidsIBA
01/2022 - 01/2008
5Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2022 - 07/2014
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 01/2005
5Tacrolimus (Prograf)FDA LinkGeneric
06/2017 - 06/2011
4AntibodiesIBA
01/2022 - 11/2018
4AutoantibodiesIBA
09/2021 - 06/2012
4Pharmaceutical PreparationsIBA
10/2020 - 06/2004
4CytokinesIBA
01/2019 - 04/2005
4activin AIBA
01/2019 - 09/2003
3Biomarkers (Surrogate Marker)IBA
01/2019 - 01/2018
3Transforming Growth Factor beta (TGF-beta)IBA
01/2019 - 05/2002
3Doxycycline (Periostat)FDA LinkGeneric
08/2009 - 02/2007
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 01/2019
2Peroxidase (Myeloperoxidase)IBA
09/2021 - 01/2019
2MethylprednisoloneFDA LinkGeneric
01/2019 - 01/2008
2tocilizumab (atlizumab)FDA Link
01/2018 - 05/2012
2FollistatinIBA
02/2017 - 01/2014
2Activins (Activin)IBA
02/2017 - 01/2014
2Bromodeoxyuridine (BrdU)IBA
01/2015 - 03/2012
2Puromycin AminonucleosideIBA
09/2014 - 01/2010
2Azathioprine (Imuran)FDA LinkGeneric
12/2012 - 05/2010
2Interleukin-6 (Interleukin 6)IBA
09/2012 - 05/2012
2FluvastatinFDA Link
08/2009 - 01/2004
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2009 - 01/2004
2nephrinIBA
08/2009 - 02/2007
2CyclinsIBA
04/2004 - 05/2002
2Cell Cycle ProteinsIBA
01/2003 - 05/2002
1Branched-Chain Amino AcidsIBA
11/2022
1anti-dsDNA autoantibodyIBA
01/2022
1Serum AlbuminIBA
01/2022
1Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
01/2022
1Antigen-Antibody Complex (Immune Complex)IBA
01/2021
1Rituximab (Mabthera)FDA Link
01/2021
1GlucocorticoidsIBA
01/2021
1Tyrosine Kinase InhibitorsIBA
11/2020
1bosutinibIBA
11/2020
1Dasatinib (BMS 354825)FDA Link
11/2020
1Collagenases (Collagenase)FDA Link
07/2020
1Ribosomal Proteins (Ribosomal Protein)IBA
01/2020
1Ferritins (Ferritin)IBA
10/2019
1Oxygen (Dioxygen)IBA
10/2019
1antiglomerular basement membrane antibodyIBA
01/2019
1N-Type Calcium Channels (N-Type Calcium Channel)IBA
01/2019
1IntegrinsIBA
01/2019
1Immune Checkpoint InhibitorsIBA
11/2018
1NivolumabIBA
11/2018

Therapy/Procedure

19Therapeutics
05/2022 - 06/2004
2Remission Induction
01/2022 - 01/2021
2Renal Dialysis (Hemodialysis)
09/2010 - 06/2004
2Nephrectomy
08/2009 - 02/2007
1Induced Abortion (Induced Abortions)
08/2021
1Plasma Exchange
01/2019